AAPL   364.11 (+0.00%)
MSFT   206.26 (+0.76%)
FB   233.42 (-1.74%)
GOOGL   1,469.93 (+1.94%)
AMZN   2,890.30 (+0.40%)
NVDA   384.49 (+0.86%)
CGC   16.45 (-0.12%)
BABA   223.60 (+3.54%)
MU   49.83 (+0.26%)
GE   6.82 (+1.19%)
TSLA   1,208.66 (+7.95%)
AMD   52.34 (-0.46%)
T   30.08 (+0.57%)
ACB   12.27 (+0.00%)
F   6.05 (+1.17%)
GILD   76.35 (+0.38%)
DIS   112.18 (-0.74%)
BAC   23.29 (+0.13%)
NFLX   476.89 (-1.80%)
BA   180.81 (+0.27%)
AAPL   364.11 (+0.00%)
MSFT   206.26 (+0.76%)
FB   233.42 (-1.74%)
GOOGL   1,469.93 (+1.94%)
AMZN   2,890.30 (+0.40%)
NVDA   384.49 (+0.86%)
CGC   16.45 (-0.12%)
BABA   223.60 (+3.54%)
MU   49.83 (+0.26%)
GE   6.82 (+1.19%)
TSLA   1,208.66 (+7.95%)
AMD   52.34 (-0.46%)
T   30.08 (+0.57%)
ACB   12.27 (+0.00%)
F   6.05 (+1.17%)
GILD   76.35 (+0.38%)
DIS   112.18 (-0.74%)
BAC   23.29 (+0.13%)
NFLX   476.89 (-1.80%)
BA   180.81 (+0.27%)
AAPL   364.11 (+0.00%)
MSFT   206.26 (+0.76%)
FB   233.42 (-1.74%)
GOOGL   1,469.93 (+1.94%)
AMZN   2,890.30 (+0.40%)
NVDA   384.49 (+0.86%)
CGC   16.45 (-0.12%)
BABA   223.60 (+3.54%)
MU   49.83 (+0.26%)
GE   6.82 (+1.19%)
TSLA   1,208.66 (+7.95%)
AMD   52.34 (-0.46%)
T   30.08 (+0.57%)
ACB   12.27 (+0.00%)
F   6.05 (+1.17%)
GILD   76.35 (+0.38%)
DIS   112.18 (-0.74%)
BAC   23.29 (+0.13%)
NFLX   476.89 (-1.80%)
BA   180.81 (+0.27%)
AAPL   364.11 (+0.00%)
MSFT   206.26 (+0.76%)
FB   233.42 (-1.74%)
GOOGL   1,469.93 (+1.94%)
AMZN   2,890.30 (+0.40%)
NVDA   384.49 (+0.86%)
CGC   16.45 (-0.12%)
BABA   223.60 (+3.54%)
MU   49.83 (+0.26%)
GE   6.82 (+1.19%)
TSLA   1,208.66 (+7.95%)
AMD   52.34 (-0.46%)
T   30.08 (+0.57%)
ACB   12.27 (+0.00%)
F   6.05 (+1.17%)
GILD   76.35 (+0.38%)
DIS   112.18 (-0.74%)
BAC   23.29 (+0.13%)
NFLX   476.89 (-1.80%)
BA   180.81 (+0.27%)
Log in

OTCMKTS:ELOXEloxx Pharmaceuticals Stock Price, Forecast & News

$3.13
+0.04 (+1.29 %)
(As of 07/2/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.05
Now: $3.13
$3.18
50-Day Range
$2.50
MA: $3.19
$3.65
52-Week Range
$1.44
Now: $3.13
$10.00
Volume61,216 shs
Average Volume155,106 shs
Market Capitalization$125.60 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Its lead program is ELX-02, which is in Phase I clinical trial, which focuses on the treatment of cystic fibrosis and cystinosis patients with diagnosed nonsense mutations. The company was founded in 2013 and is headquartered in Waltham, Massachusetts.
Read More
Eloxx Pharmaceuticals logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.29 out of 5 stars


Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ELOX
CUSIPN/A
CIKN/A
Phone858-909-0749

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$125.60 million
Next Earnings DateN/A
OptionableNot Optionable

Receive ELOX News and Ratings via Email

Sign-up to receive the latest news and ratings for ELOX and its competitors with MarketBeat's FREE daily newsletter.

Eloxx Pharmaceuticals (OTCMKTS:ELOX) Frequently Asked Questions

How has Eloxx Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

Eloxx Pharmaceuticals' stock was trading at $2.88 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ELOX stock has increased by 8.7% and is now trading at $3.13. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Eloxx Pharmaceuticals?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eloxx Pharmaceuticals in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Eloxx Pharmaceuticals.

How were Eloxx Pharmaceuticals' earnings last quarter?

Eloxx Pharmaceuticals (OTCMKTS:ELOX) posted its earnings results on Thursday, May, 7th. The company reported ($0.20) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.09. View Eloxx Pharmaceuticals' earnings history.

What price target have analysts set for ELOX?

6 brokers have issued 12-month price objectives for Eloxx Pharmaceuticals' stock. Their forecasts range from $3.00 to $10.00. On average, they anticipate Eloxx Pharmaceuticals' stock price to reach $6.50 in the next year. This suggests a possible upside of 107.7% from the stock's current price. View analysts' price targets for Eloxx Pharmaceuticals.

Has Eloxx Pharmaceuticals been receiving favorable news coverage?

Media headlines about ELOX stock have been trending very negative on Thursday, InfoTrie Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Eloxx Pharmaceuticals earned a coverage optimism score of -3.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news about Eloxx Pharmaceuticals.

Who are some of Eloxx Pharmaceuticals' key competitors?

What other stocks do shareholders of Eloxx Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Eloxx Pharmaceuticals investors own include BioXcel Therapeutics (BTAI), Novavax (NVAX), Opko Health (OPK), Aldeyra Therapeutics (ALDX), Allena Pharmaceuticals (ALNA), Amarin (AMRN), Ardelyx (ARDX), Aurinia Pharmaceuticals (AUPH), Axsome Therapeutics (AXSM) and Boeing (BA).

Who are Eloxx Pharmaceuticals' key executives?

Eloxx Pharmaceuticals' management team includes the following people:
  • Mr. Robert E. Ward, Chairman & CEO (Age 60)
  • Dr. Silvia Noiman, Founder & Director (Age 62)
  • Mr. Gregory L. Weaver CPA, M.B.A., Chief Financial Officer (Age 62)
  • Dr. Pedro Huertas, Chief Medical Officer (Age 63)
  • Dr. Colin Scott M.B., Ch.B., Medical Director (Age 66)

What is Eloxx Pharmaceuticals' stock symbol?

Eloxx Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ELOX."

How do I buy shares of Eloxx Pharmaceuticals?

Shares of ELOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Eloxx Pharmaceuticals' stock price today?

One share of ELOX stock can currently be purchased for approximately $3.13.

How big of a company is Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals has a market capitalization of $125.60 million.

What is Eloxx Pharmaceuticals' official website?

The official website for Eloxx Pharmaceuticals is www.eloxxpharma.com.

How can I contact Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals' mailing address is 950 WINTER STREET, WALTHAM MA, 02451. The company can be reached via phone at 858-909-0749 or via email at [email protected]

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.